News Otsuka Corporation

Equities

4768

JP3188200004

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-24 am EDT			5-day change	1st Jan Change
3,145 ^JPY	+0.10%		+0.19%	+8.21%

Apr. 09	H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	MT
Mar. 29	Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy	Apr. 09	MT
Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation	Mar. 29	MT
Split: 2 of 1	Mar. 27	FA
EU Commission Green-lights Lundbeck, Otsuka's Abilify Maintena as Maintenance Treatment of Schizophrenia	Mar. 27	MT
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	Mar. 17	MT
Jefferies Adjusts Otsuka Corporation’s Price Target to 7,850 Yen From 7,100 Yen, Keeps at Buy	Mar. 11	MT
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	Feb. 26	DJ
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	Feb. 16	MT
Otsuka Holdings Lowers 2023 Profit Outlook	Feb. 13	MT
Japan's Nikkei cruises to 34-year peak, briefly breaching 38,000 range	Feb. 13	RE
Japan's Nikkei soars to 34-year high on chip shares, earnings	Feb. 12	RE
Phase 3 Trial for Otsuka's Alzheimer's-related Agitation Treatment Fails to Meet Primary Endpoint	Feb. 12	MT
Otsuka's drug for Alzheimer's disease agitation fails in late stage study	Feb. 12	RE
Otsuka Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 01	CI
Ionis Pharmaceuticals Says Potential Angioedema Treatment Met Primary Endpoint of Phase 3 Study	Jan. 22	MT
Final dividend	Dec. 27	FA
Ionis Pharmaceuticals Signs Europe Licensing Deal With Otsuka for Donidalorsen in Hereditary Angioedema	Dec. 18	MT
Otsuka's Unit Remains as MicroPort Scientific's Thai Distributor Until 2026	Dec. 18	MT
Otsuka Unit Buys New York-Based Provider of Women Health Products	Dec. 05	MT
Happiness Planet, Ltd. announced that it has received ¥349.995 million in funding from Otsuka Corporation	Nov. 29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Otsuka Corporation

Equities

4768

JP3188200004

Summary

Filters